As of 2026-08-24, Celanese Corporation Common Stock (CE) has a 3-month relative strength percentile of 26 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 48. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.4%, relative volume 0.69×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
CE is held by 31 ETFs as of May 2026. Top owner: SCHA at 0.12% weight, $28M notional. Top 3 carry $65M.
Held by 102 ETFs · $1.5B across latest filings · largest weight 7.32% (PSCM).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.12% | $28M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.34% | $20M | — |
| VAWVanguard Materials ETF | 0.37% | $17M | +0.04 pp |
| SCHMSchwab U.S. Mid-Cap ETF | 0.11% | $16M | — |
| FNDXSchwab Fundamental U.S. Large Company Index ETF | 0.05% | $14M | — |
| RWJ | 0.58% | $11M | −0.17 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.48% | $9M | −0.22 pp |
| VONVVanguard Russell 1000 Value ETF | 0.02% | $4M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $3M | — |
| ESML | 0.09% | $2M | — |
Showing 10 of 31 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CE Jan avg: 5.60% median: 3.88% win: 75% σ: 10.98% n: 4 2022-04-12 → 2026-07-31 | CE Feb avg: -4.42% median: -0.89% win: 50% σ: 17.54% n: 4 2022-04-12 → 2026-07-31 | CE Mar avg: 12.48% median: 12.27% win: 75% σ: 15.53% n: 4 2022-04-12 → 2026-07-31 | CE Apr avg: -6.05% median: -2.43% win: 40% σ: 10.16% n: 5 2022-04-12 → 2026-07-31 | CE May avg: 0.10% median: -1.02% win: 40% σ: 14.69% n: 5 2022-04-12 → 2026-07-31 | CE Jun avg: -6.70% median: -11.28% win: 40% σ: 14.59% n: 5 2022-04-12 → 2026-07-31 | CE Jul avg: 0.89% median: -0.08% win: 40% σ: 5.60% n: 5 2022-04-12 → 2026-07-31 | CE Aug avg: -5.29% median: -6.57% win: 25% σ: 4.24% n: 4 2022-04-12 → 2026-07-31 (current) | CE Sep avg: -6.68% median: -6.16% win: 25% σ: 10.28% n: 4 2022-04-12 → 2026-07-31 | CE Oct avg: -4.59% median: -8.00% win: 25% σ: 7.36% n: 4 2022-04-12 → 2026-07-31 | CE Nov avg: -0.20% median: 9.99% win: 75% σ: 28.31% n: 4 2022-04-12 → 2026-07-31 | CE Dec avg: 0.85% median: -1.60% win: 50% σ: 8.10% n: 4 2022-04-12 → 2026-07-31 |